Kim Bong-jun Vice President Increases Stock Holdings via HEM Pharma Stock Purchase Options Exercise

Kim Bong-jun, vice president of HEM Pharma (376270), increased his stock holdings by exercising stock purchase options, raising his share ownership to 19,000 shares as of June 22, 2026. This represents a 6,000-share increase from November 8, 2024, with his ownership ratio rising to 0.26% from 0.19%. Kim exercised the options on June 15, 2026, at a price of 14,590 KRW per share. HEM Pharma's stock closed at 47,750 KRW on June 22, down 6.37% from the prior day. As of the latest financial report, HEM Pharma reported total assets of 518 billion KRW, liabilities of 466 billion KRW, and equity of 52 billion KRW, alongside revenue of 130 billion KRW and a net loss of 237 billion KRW. The company, a science and engineering R&D firm listed on KOSDAQ since December 30, 2016, continues to operate amid persistent performance challenges.